Giuseppe Danilo Norata/LinkedIn
Nov 22, 2025, 10:21
Giuseppe Danilo Norata At the Cardiorisk 2025 Meeting in Alexandria
Giuseppe Danilo Norata, Professor of Pharmacology at University of Milan, posted on LinkedIn:
”I’m grateful to Prof. Ashraf Reda, Atef Elbahry, Adel El Etriby and Hany Ragy for the kind invitation to the Cardiorisk 2025 meeting in Alexandria, Egypt.
It was a pleasure to be part of the European Atherosclerosis Society-EAVA Joint session and of the International Lipid Summit and to engage with colleagues and experts in cardiovascular research, exchange ideas, and discuss emerging trends in the field.”

Keep up with Hemostasis Today.
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed
